Syncom Formulations (India) (SYNCOMF) Share Price hits fresh 52-week high on NSE

Syncom Formulations (India) Share Price is in focus after Syncom Formulations (India) Ltd. (SYNCOMF) touched a fresh 52-week high of Rs 27.53 and was trading at Rs 25.03, down Rs 1.29 or 4.90% from the previous close of Rs 26.32. The company’s market capitalisation stood at Rs 2,086.8 crore as of 30 September 2026 at 9:22 AM IST. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. The move places Syncom Formulations (India) Share Price into today’s key Stock Market Today and Share Market Today screens, where 52 Week High Stocks and Market Movers often draw attention. Univest is tracking the stock because the price action, valuation and healthcare sector backdrop can all be read from verified numbers rather than speculation.

Syncom Formulations (India) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 25.03
Previous Close	Rs 26.32
Today's Move	Rs -1.29 (-4.9%)
Open	Rs 27.44
High	Rs 27.53
Low	Rs 25
Market Capitalisation	Rs 2,086.8 crore

Syncom Formulations (India) Ltd. (SYNCOMF) traded at Rs 25.03 versus the previous close of Rs 26.32, a fall of 4.9%. The stock opened at Rs 27.44, reached a high of Rs 27.53 and touched a low of Rs 25.

Syncom Formulations (India) Share Price opened at Rs 27.44, touched a day high of Rs 27.53, and a day low of Rs 25.00 before last trading at Rs 25.03. That means the stock moved Rs 1.29 below the previous close and finished the first part of the session below the fresh 52-week high it printed today. For readers following Syncom Formulations (India) Share Price Today, the key fact is straightforward: the stock made a one-year high of Rs 27.53 and then traded lower from that level during the same session. This is a factual price-action event, not a statement about why the move happened. Univest data confirms the high print, the current price and the day’s range, which together define the stock’s intraday path. In Stock Updates and Market News coverage, such a pattern is often tracked closely because it shows where the current share price stands relative to the new yearly high.

At this stage, Syncom Formulations (India) Share Price is trading below the day’s peak, but the fresh 52-week high remains the central event. The current market value and the intraday range are enough to understand what happened today without adding any unverified explanation. The next natural question is whether the company’s valuation and operating metrics support the attention around Syncom Formulations (India) Share Price.

Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 2,086.8 crore
P/E Ratio	28.93x
P/B Ratio	5.63x
ROE	20.19%
ROCE	26.8%
EPS	Rs 0.91
Book Value Per Share	Rs 4.68
Dividend Yield	0.38%

Syncom Formulations (India) Ltd. (SYNCOMF) fundamental metrics show P/E 28.93x, P/B 5.63x, ROE 20.19%, ROCE 26.8%. Read together, these ratios describe the company's position rather than a recommendation.

Syncom Formulations (India) Ltd. has a market capitalisation of Rs 2,086.8 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 28.93x, P/B at 5.63x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.19% and ROCE of 26.8%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 0.91, book value per share of Rs 4.68, dividend yield of 0.38%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.52x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	28.93x
Benchmark Median P/E	32.52x
Benchmark Average P/E	49.59x
Benchmark P/E Range	3.4x to 699.02x
Company P/B Ratio	5.63x
Benchmark Median P/B	2.89x
Company ROE	20.19%
Benchmark Median ROE	11.7%
Company ROCE	26.8%
Benchmark Median ROCE	13.46%
Company Market Capitalisation	Rs 2,086.8 crore
Benchmark Median Market Cap	Rs 773.14 crore

Syncom Formulations (India) Ltd. (SYNCOMF) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Syncom Formulations (India) Ltd. (SYNCOMF) has a P/E ratio of 28.93x, which is below the benchmark median of 32.52x, a difference of -11.04%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Syncom Formulations (India) Ltd. (SYNCOMF) has a ROE of 20.19%, which is above the benchmark median of 11.7%, a difference of +72.56%. Syncom Formulations (India) Ltd. (SYNCOMF) has a ROCE of 26.8%, which is above the benchmark median of 13.46%, a difference of +99.11%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Venus Remedies Ltd.	VENUSREM	2,179.75	19.69	3.33	16.79	21.88
Sai Parenteral's Ltd.	SAIPARENT	2,251.15	134.55	2.85	4.88	6.1
Windlas Biotech Ltd.	WINDLAS	2,268.54	33.96	4.39	12.52	16.06
Beta Drugs Ltd.	BETA	2,269.07	55.36	8.76	23.95	25.23
Indoco Remedies Ltd.	INDOCO	2,299.28	441.02	2.49	-10.13	0.79

Syncom Formulations (India) Ltd. (SYNCOMF) has a P/E ratio of 28.93x compared with the displayed peer median of 55.36x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 20.19% compares with a peer median of 12.52% across the companies shown in the table. ROCE stood at 26.8% versus the displayed peer median of 16.06%, providing a capital-efficiency comparison. Syncom Formulations (India) Ltd. (SYNCOMF) has a market capitalisation of Rs 2,086.8 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Syncom Formulations (India)

• Syncom Formulations (India) Share Price touched a fresh 52-week high of Rs 27.53 during the session.
• The stock was last trading at Rs 25.03 after a decline of Rs 1.29, or 4.90%, from the previous close.
• Market capitalisation stood at Rs 2,086.8 crore, placing Syncom Formulations (India) Share Price within the current Healthcare universe.
• P/E is 28.93, which is below the industry median of 32.52 and below the industry average of 49.59.
• ROE is 20.19% and ROCE is 26.8%, both above the same-industry median and average benchmarks.

About Syncom Formulations (India)

Syncom Formulations (India) Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. For readers following Syncom Formulations (India) Share Price, the key company identifiers remain its NSE and BSE listing presence, market capitalisation of Rs 2,086.8 crore, and the latest Jun 2026 revenue of Rs 125.53 crore. Syncom Formulations (India) Share Price can therefore be tracked alongside company financials, valuation metrics and sector context on Univest.

Frequently Asked Questions

1) Why is Syncom Formulations (India) Share Price in focus today?

Ans. Syncom Formulations (India) Share Price is in focus because it touched a fresh 52-week high of Rs 27.53 and was trading at Rs 25.03, with a market capitalisation of Rs 2,086.8 crore.

2) What is the current Syncom Formulations (India) Share Price?

Ans. Syncom Formulations (India) Share Price was last trading at Rs 25.03. It moved below the previous close of Rs 26.32 after touching a day high of Rs 27.53 earlier in the session.

3) What was the fresh 52-week high for Syncom Formulations (India) Share Price?

Ans. Syncom Formulations (India) Share Price touched a fresh 52-week high of Rs 27.53. According to latest Univest data, that level is also the day’s high, while the current price was lower at Rs 25.03.

4) How did Syncom Formulations (India) Share Price move today?

Ans. Syncom Formulations (India) Share Price fell Rs 1.29, or 4.90%, versus the previous close. It opened at Rs 27.44, touched Rs 27.53, and later traded as low as Rs 25.00.

5) What valuation metrics are available for Syncom Formulations (India) Share Price?

Ans. Syncom Formulations (India) Share Price has a P/E ratio of 28.93 and a P/B ratio of 5.63. It also shows EPS of Rs 0.91, book value of Rs 4.68 and dividend yield of 0.38%.

6) How does Syncom Formulations (India) Share Price compare with the industry benchmark?

Ans. Syncom Formulations (India) Share Price trades below the industry median P/E of 32.52 and above the industry median P/B of 2.89. Its ROE of 20.19% and ROCE of 26.8% are also above benchmark levels.

7) Which peer numbers stand out for Syncom Formulations (India) Share Price comparison?

Ans. Compared with peers such as Venus Remedies, Windlas Biotech and Beta Drugs, Syncom Formulations (India) Share Price sits with a lower P/E than some peers and a stronger ROCE than several names in the same industry set.

8) What should readers monitor next for Syncom Formulations (India) Share Price?

Ans. Readers can monitor whether Syncom Formulations (India) Share Price holds near the fresh yearly high area, how it trades against the previous close of Rs 26.32, and whether the current valuation stays aligned with sector benchmarks.

Track Syncom Formulations (India) Share Price on Univest

Use Syncom Formulations (India) Ltd. (SYNCOMF) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors tracking Syncom Formulations (India) Share Price on Univest can review live share price, market cap, P/E ratio, P/B ratio, ROE, ROCE, EPS, book value, dividend yield and the fresh 52-week high in one place. Univest keeps the stock view focused on verified numbers, helping readers compare Syncom Formulations (India) Share Price with peers and the healthcare sector benchmark.